GZERO AI
Meet Isomorphic Labs, the Google spinoff that aims to cure you
The logo for Isomorphic Labs is displayed on a tablet in this illustration.
Igor Golovniov/SOPA Images/Sipa USA via Reuters
April 01, 2025
In 2024, Demis Hassabiswon a Nobel Prize in chemistry for his work in predicting protein structures through his company, Isomorphic Labs. The lab, which broke off from Google's DeepMind in 2021, raised $600 million from investors in a new funding round led by Thrive Capital on Monday. The company did not disclose a valuation.
Isomorphic uses artificial intelligence to discover new drugs through its AlphaFold technology, which was at the center of Hassabis’s Nobel win last year. Ultimately, Hassabis wants to do something that’s not exactly simple: He’s vowed to “solve all disease with the help of AI.”
Isomorphic is already working with big pharmaceutical companies such as Eli Lilly and Novartis, inking deals with the two drugmakers last year worth $3 billion. It plans to use the new money to improve its AI tools and to move its drugs toward clinical testing.More For You
Most Popular
Mastercard Economic Institute's Outlook 2026 explores the forces redefining global business. Tariffs, technology, and transformation define an adaptive economy for the year ahead. Expect moderate growth amid easing inflation, evolving fiscal policies, and rapid AI adoption, driving productivity. Digital transformation for SMEs and shifts in trade and consumer behavior will shape strategies worldwide. Stay ahead with insights to help navigate complexity and seize emerging opportunities. Learn more here.
- YouTube
Gotta maximize sleigh-holder value. #PUPPETREGIME
- YouTube
While Gaza and Ukraine dominate headlines, dozens of other conflicts—from Haiti to Myanmar to the Congo—get far less global attention. International Crisis Group’s Comfort Ero joins Ian Bremmer on GZERO World.
© 2025 GZERO Media. All Rights Reserved | A Eurasia Group media company.